the summary of clinical evaluation as referred to in Annex XIV, and relevant information on post-market clinical follow-up;
an achoimre ar mheastóireacht chliniciúil amhail dá dtagraítear in Iarscríbhinn XIV, agus faisnéis ábhartha maidir le bearta leantacha cliniciúla iarmhargaidh;